novoGi
GI Disease Management
Company Overview
Snapshot
Founded in April 1996, novoGi operated with 1–10 employees. The company raised a total of $18.5M across one funding round from six investors, including Evergreen Venture Partners and Israel HealthCare Ventures. A key milestone for the company was its acquisition of an exclusive license to brand and market a next-generation GI endoscopic video processing standalone solution in December 2012.
Business overview
novoGi specializes in providing solutions for gastrointestinal (GI) disease management within the Health Tech & Life Sciences sector. The company's core technology leverages proprietary nitinol-based elements to facilitate natural healing through tissue-sparing, uniform BioDynamix anastomosis. Its product line is designed to press together resected tissue ends, enabling natural intestinal reconnection after surgical removal of sections, such as in colon cancer treatment. novoGi operates in the medical devices, medical technologies, and gastroenterology categories, serving the healthcare industry, particularly providers, in geomarkets like the United States and France.
Strategic signal
In March 2014, novoGi underwent a downsizing event, as reported by Globes. This operational adjustment indicates a strategic recalibration within the company, potentially reflecting market shifts or internal restructuring efforts. For investors, this signals a period of adaptation and efficiency focus for the company.
Company Intelligence Q&A
- What is novoGi's primary focus?
- novoGi focuses on providing a range of solutions for gastrointestinal (GI) disease management, utilizing proprietary technology for natural healing with tissue-sparing, uniform BioDynamix anastomosis.
- When was novoGi founded?
- novoGi was founded in April 1996.
- What significant license acquisition did novoGi make?
- In December 2012, novoGi acquired an exclusive license to brand and market a next-generation GI endoscopic video processing standalone solution.
- What was a notable operational event for novoGi?
- In March 2014, novoGi underwent a downsizing event, as reported by Globes, indicating a strategic recalibration within the company.
- Which investors participated in novoGi's funding round?
- novoGi received funding from investors including Evergreen Venture Partners and Israel HealthCare Ventures.